Skip to main content
. 2011 Oct;6(4):290–297.

Table 7.

The highest risk patients for infective endocarditis

1. Prosthetic cardiac valve
2. Previous IE
3. Selected congenital heart disease
• Nonrepaired cyanotic congenital heart disease, including palliative shunts and conduits
• Repaired (surgically/by catheter intervention) congenital heart defect with prosthetic material or device during the first 6 months after the procedure (until endothelialization occurs)
• Repaired congenital heart disease with residual defects at the side or adjacent to the site of a prosthetic patch or device

* only AHA recommend EI prophylaxis for Cardiac transplantation recipients who develop cardiac valvulopathy

Adapted from (3,28)